Scientists design nanoparticle drug delivery system for levodopa
Scientists have developed a nanoparticle drug delivery system designed to enhance brain delivery of levodopa, the mainstay treatment for…
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Scientists have developed a nanoparticle drug delivery system designed to enhance brain delivery of levodopa, the mainstay treatment for…
Data from a brief gait and posture assessment using wearable sensors — taking just a few minutes in the clinic…
Treatment with investigational antibody therapy prasinezumab tended to slow the progression of motor symptoms in people with early-stage…
The U.S. National Institutes of Health (NIH) launched a consortium to support clinical studies designed to better understand the link…
Researchers in China have identified three genes — GPX2, CR1, and ZNF556 — with increased activity in people with…
The Parkinson’s disease therapy entacapone may disrupt the balance of microbes in the gut by starving them of iron,…
Researchers have developed a “double-hit” rat model of Parkinson’s disease wherein neurodegeneration is driven by both genetic susceptibility and…
Among adults in the U.K., poor hand grip strength is associated with an increased risk of developing Parkinson’s disease,…
Metabolic syndrome, a cluster of conditions that can increase the risk of heart disease, diabetes, and stroke, is associated with…
Inbrain Neuroelectronics has raised $50 million in funding to continue developing its brain-computer interface (BCI) technology using ultra-thin…
Get regular updates to your inbox.